metformin and tamoxifen

metformin has been researched along with tamoxifen in 37 studies

Research

Studies (37)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's4 (10.81)29.6817
2010's27 (72.97)24.3611
2020's6 (16.22)2.80

Authors

AuthorsStudies
Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL1
Ahlin, G; Artursson, P; Bergström, CA; Gustavsson, L; Karlsson, J; Larsson, R; Matsson, P; Norinder, U; Pedersen, JM1
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A1
Choi, SS; Contrera, JF; Hastings, KL; Kruhlak, NL; Sancilio, LF; Weaver, JL; Willard, JM1
Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ1
Glen, RC; Lowe, R; Mitchell, JB1
Afshari, CA; Eschenberg, M; Hamadeh, HK; Lee, PH; Lightfoot-Dunn, R; Morgan, RE; Qualls, CW; Ramachandran, B; Trauner, M; van Staden, CJ1
Ekins, S; Williams, AJ; Xu, JJ1
Artursson, P; Haglund, U; Karlgren, M; Kimoto, E; Lai, Y; Norinder, U; Vildhede, A; Wisniewski, JR1
Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ1
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K1
Duarte, D; Esteves da Silva, JCG; Ferreira, PJO; González-Berdullas, P; Magalhães, CM; Núnez-Montenegro, A; Pinto da Silva, L; Rodríguez-Borges, JE; Vale, N1
Correia, C; Duarte, D; Ferreira, A; Moreira, S; Vale, N; Vasconcelos, MH; Xavier, CPR1
Erdemoglu, E; Giray, SG; Güney, M; Mungan, T; Take, G1
Berstein, LM; Santen, RJ; Wang, JP; Yue, W1
Arun, B; Brown, PH; Castiglione, M; Cuzick, J; DeCensi, A; Dunn, B; Forbes, JF; Glaus, A; Howell, A; Vogel, V; von Minckwitz, G; Zwierzina, H1
Flomenberg, N; Goldberg, A; Howell, A; Ko, YH; Lin, Z; Lisanti, MP; Martinez-Outschoorn, UE; Pavlides, S; Pestell, RG; Sotgia, F; Wang, C1
Bershteĭn, LM; Semiglazov, VF1
Marc, J; Mlakar, V1
Chen, S; Guo, Y; Lai, X; Liu, W; Ma, J; Wei, Y; Xue, Y; Yu, S; Zhang, J; Zhang, Y; Zhong, C1
Böhmer, FD; Kirches, E; Mawrin, C; Pachow, D; Petermann, A; Wallesch, M; Wilisch-Neumann, A1
Asara, JM; German, NJ; Gonzalez-Herrera, KN; Haigis, MC; Janzer, A; Struhl, K1
Cho, YH; Jang, SY; Kim, A; Kim, C; Kim, CH; Kim, JH; Kim, JK; Lee, JY1
Cuzick, J; Sestak, I1
Blake, C; Lucic, A1
Choi, J; Kim, A; Kim, C; Kim, J; Lee, J1
Berstein, LM; Krasil'nikov, MA; Prokhorov, NS; Scherbakov, AM; Semina, SE; Sorokin, DV; Tatarskiy, VV1
Choi, Y; Jang, SY; Kim, A; Kim, C; Kim, J; Lee, J1
Esteban, S; Peper, FE; Terrasa, SA1
Bell, RJ; Brown, KA; Chipman, M; Davis, SR; Edwards, A; Jane, F; McNeilage, J; Piessens, S; Robinson, PJ; White, S; Woinarski, J1
Bens, A; Bernstein, JL; Cronin-Fenton, D; Friis, S; Langballe, R; Mellemkjaer, L1
Guo, M; Huang, W; Zhou, JJ1
Chen, H; Li, J; Li, P; Liu, J; Liu, P; Miao, Y; Wang, R1
Burov, SV; Haq, S; Harless, W; Markvicheva, E; Qorri, B; Sambi, M; Samuel, V; Szewczuk, MR1
Dietze, EC; Jones, VC; Jovanovic-Talisman, T; McCune, JS; Seewaldt, VL1
Gao, H; Ingle, JN; Kim, W; Qin, S; Wang, L; Weinshilboum, RM1

Reviews

6 review(s) available for metformin and tamoxifen

ArticleYear
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
    Drug discovery today, 2016, Volume: 21, Issue:4

    Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk

2016
Preventive therapy for breast cancer: a consensus statement.
    The Lancet. Oncology, 2011, Volume: 12, Issue:5

    Topics: Anastrozole; Androstadienes; Anti-Inflammatory Agents, Non-Steroidal; Anticarcinogenic Agents; Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Breast Neoplasms; Consensus Development Conferences as Topic; Diphosphonates; Estrogen Receptor Modulators; Expert Testimony; Female; Fenretinide; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Metformin; Nitriles; Norpregnenes; Piperidines; Premenopause; Pyrrolidines; Raloxifene Hydrochloride; Retinoids; Selective Estrogen Receptor Modulators; Tamoxifen; Tetrahydronaphthalenes; Thiophenes; Triazoles

2011
[Breast cancer subtypes and their endocrine-metabolic basis; practical aspects].
    Voprosy onkologii, 2011, Volume: 57, Issue:5

    Topics: Age Factors; Antineoplastic Agents, Hormonal; Biomarkers, Tumor; BRCA1 Protein; Breast Neoplasms; Female; Gastrointestinal Hormones; Gonadal Steroid Hormones; Humans; Hypoglycemic Agents; Metformin; Molecular Targeted Therapy; Neoplasms, Hormone-Dependent; Postmenopause; Premenopause; Receptor, ErbB-2; Tamoxifen

2011
Update on breast cancer risk prediction and prevention.
    Current opinion in obstetrics & gynecology, 2015, Volume: 27, Issue:1

    Topics: Age of Onset; Aromatase Inhibitors; Aspirin; Biomarkers, Tumor; Breast Neoplasms; Diphosphonates; Female; Humans; Metformin; Neoplasm Recurrence, Local; Neoplasms, Hormone-Dependent; Selective Estrogen Receptor Modulators; Tamoxifen; Treatment Outcome

2015
Preventive drug therapy and contralateral breast cancer: summary of the evidence of clinical trials and observational studies.
    Acta oncologica (Stockholm, Sweden), 2019, Volume: 58, Issue:11

    Topics: Anti-Inflammatory Agents, Non-Steroidal; Antihypertensive Agents; Antineoplastic Agents; Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Breast Neoplasms; Diphosphonates; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Metformin; Neoplasms, Second Primary; Observational Studies as Topic; Randomized Controlled Trials as Topic; Retinoids; Tamoxifen

2019
Metformin and Chemoprevention: Potential for Heart-Healthy Targeting of Biologically Aggressive Breast Cancer.
    Frontiers in public health, 2020, Volume: 8

    Topics: Breast Neoplasms; Female; Humans; Metformin; Raloxifene Hydrochloride; Selective Estrogen Receptor Modulators; Tamoxifen

2020

Trials

1 trial(s) available for metformin and tamoxifen

ArticleYear
The benefits of adding metformin to tamoxifen to protect the endometrium-A randomized placebo-controlled trial.
    Clinical endocrinology, 2018, Volume: 89, Issue:5

    Topics: Adult; Aged; Blood Glucose; Body Mass Index; Double-Blind Method; Endometrium; Fasting; Female; Humans; Hypoglycemic Agents; Insulin Resistance; Metformin; Middle Aged; Postmenopause; Tamoxifen; Waist Circumference

2018

Other Studies

30 other study(ies) available for metformin and tamoxifen

ArticleYear
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
    Current drug discovery technologies, 2004, Volume: 1, Issue:4

    Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration

2004
Structural requirements for drug inhibition of the liver specific human organic cation transport protein 1.
    Journal of medicinal chemistry, 2008, Oct-09, Volume: 51, Issue:19

    Topics: Cell Line; Computer Simulation; Drug Design; Gene Expression Profiling; Humans; Hydrogen Bonding; Liver; Molecular Weight; Organic Cation Transporter 1; Pharmaceutical Preparations; Predictive Value of Tests; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Structure-Activity Relationship

2008
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
    Chemical research in toxicology, 2010, Volume: 23, Issue:1

    Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship

2010
Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models.
    Toxicology mechanisms and methods, 2008, Volume: 18, Issue:2-3

    Topics:

2008
Developing structure-activity relationships for the prediction of hepatotoxicity.
    Chemical research in toxicology, 2010, Jul-19, Volume: 23, Issue:7

    Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes

2010
Predicting phospholipidosis using machine learning.
    Molecular pharmaceutics, 2010, Oct-04, Volume: 7, Issue:5

    Topics: Animals; Artificial Intelligence; Databases, Factual; Drug Discovery; Humans; Lipidoses; Models, Biological; Phospholipids; Support Vector Machine

2010
Interference with bile salt export pump function is a susceptibility factor for human liver injury in drug development.
    Toxicological sciences : an official journal of the Society of Toxicology, 2010, Volume: 118, Issue:2

    Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Assay; Biological Transport; Cell Line; Cell Membrane; Chemical and Drug Induced Liver Injury; Cytoplasmic Vesicles; Drug Evaluation, Preclinical; Humans; Liver; Rats; Reproducibility of Results; Spodoptera; Transfection; Xenobiotics

2010
A predictive ligand-based Bayesian model for human drug-induced liver injury.
    Drug metabolism and disposition: the biological fate of chemicals, 2010, Volume: 38, Issue:12

    Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands

2010
Classification of inhibitors of hepatic organic anion transporting polypeptides (OATPs): influence of protein expression on drug-drug interactions.
    Journal of medicinal chemistry, 2012, May-24, Volume: 55, Issue:10

    Topics: Atorvastatin; Biological Transport; Drug Interactions; Estradiol; Estrone; HEK293 Cells; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; In Vitro Techniques; Least-Squares Analysis; Liver; Liver-Specific Organic Anion Transporter 1; Models, Molecular; Multivariate Analysis; Organic Anion Transporters; Organic Anion Transporters, Sodium-Independent; Protein Isoforms; Pyrroles; Solute Carrier Organic Anion Transporter Family Member 1B3; Structure-Activity Relationship; Transfection

2012
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.
    Drug metabolism and disposition: the biological fate of chemicals, 2012, Volume: 40, Issue:12

    Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship

2012
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
    Toxicological sciences : an official journal of the Society of Toxicology, 2013, Volume: 136, Issue:1

    Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests

2013
Single-molecule chemiluminescent photosensitizer for a self-activating and tumor-selective photodynamic therapy of cancer.
    European journal of medicinal chemistry, 2019, Dec-01, Volume: 183

    Topics: Cell Line, Tumor; Cell Survival; Computer Simulation; Humans; Imidazoles; Light; Neoplasms; Photochemotherapy; Photosensitizing Agents; Proof of Concept Study; Pyrazines; Singlet Oxygen; Thermodynamics

2019
Development of potent CPP6-gemcitabine conjugates against human prostate cancer cell line (PC-3).
    RSC medicinal chemistry, 2020, Feb-01, Volume: 11, Issue:2

    Topics:

2020
Effects of metformin on mammalian target of rapamycin in a mouse model of endometrial hyperplasia.
    European journal of obstetrics, gynecology, and reproductive biology, 2009, Volume: 145, Issue:2

    Topics: Animals; Carrier Proteins; Cell Proliferation; Disease Models, Animal; Endometrial Hyperplasia; Endometrium; Estradiol; Female; Metformin; Mice; Mice, Inbred BALB C; Phosphotransferases (Alcohol Group Acceptor); Ribosomal Protein S6 Kinases, 90-kDa; Tamoxifen; TOR Serine-Threonine Kinases

2009
Isolated and combined action of tamoxifen and metformin in wild-type, tamoxifen-resistant, and estrogen-deprived MCF-7 cells.
    Breast cancer research and treatment, 2011, Volume: 128, Issue:1

    Topics: Adenylate Kinase; Antineoplastic Agents, Hormonal; Apoptosis; Aromatase; Aromatase Inhibitors; Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; Drug Resistance, Neoplasm; Drug Synergism; Estrogens; Female; Humans; Metformin; Phosphorylation; Proliferating Cell Nuclear Antigen; Ribosomal Protein S6 Kinases, 70-kDa; Tamoxifen

2011
Anti-estrogen resistance in breast cancer is induced by the tumor microenvironment and can be overcome by inhibiting mitochondrial function in epithelial cancer cells.
    Cancer biology & therapy, 2011, Nov-15, Volume: 12, Issue:10

    Topics: Apoptosis; Apoptosis Regulatory Proteins; Arsenic Trioxide; Arsenicals; Breast Neoplasms; Cell Line, Tumor; Coculture Techniques; Doxorubicin; Drug Resistance, Neoplasm; Estradiol; Estrogen Receptor Modulators; Female; Fibroblasts; Fulvestrant; Humans; Hypoglycemic Agents; Intracellular Signaling Peptides and Proteins; Ketone Bodies; Lactic Acid; Metformin; Mitochondria; Oxides; Phosphoric Monoester Hydrolases; Poly(ADP-ribose) Polymerase Inhibitors; Tamoxifen; Tumor Microenvironment

2011
Highlights from the latest pharmacogenomic genome-wide association studies.
    Pharmacogenomics, 2013, Volume: 14, Issue:4

    Topics: Animals; Antimetabolites, Antineoplastic; Antineoplastic Agents, Hormonal; Biomedical Research; Breast Neoplasms; Cell Cycle Proteins; Chromosomes, Human, Pair 10; Diabetes Mellitus, Type 2; DNA-Binding Proteins; Drug Industry; Exons; Female; Genetic Loci; Genetic Variation; Genome-Wide Association Study; Humans; Male; Metabolism; Metformin; Methotrexate; Neoplasm Proteins; Organic Anion Transporters; Polymorphism, Single Nucleotide; Protein Serine-Threonine Kinases; Tamoxifen; Tumor Suppressor Proteins

2013
Metformin enhances tamoxifen-mediated tumor growth inhibition in ER-positive breast carcinoma.
    BMC cancer, 2014, Mar-11, Volume: 14

    Topics: Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; Female; Humans; Mammary Neoplasms, Experimental; MCF-7 Cells; Metformin; Mice; Mice, Nude; Receptors, Estrogen; Signal Transduction; Tamoxifen; Xenograft Model Antitumor Assays

2014
Re-evaluation of cytostatic therapies for meningiomas in vitro.
    Journal of cancer research and clinical oncology, 2014, Volume: 140, Issue:8

    Topics: Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Dacarbazine; DNA Methylation; DNA Modification Methylases; DNA Repair Enzymes; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Erlotinib Hydrochloride; Humans; Hydroxyurea; Losartan; Meningeal Neoplasms; Meningioma; Metformin; Mifepristone; Neurofibromin 2; Promoter Regions, Genetic; Quinazolines; Radiation Tolerance; Tamoxifen; Temozolomide; Tumor Suppressor Proteins; Verapamil

2014
Metformin and phenformin deplete tricarboxylic acid cycle and glycolytic intermediates during cell transformation and NTPs in cancer stem cells.
    Proceedings of the National Academy of Sciences of the United States of America, 2014, Jul-22, Volume: 111, Issue:29

    Topics: Aminoimidazole Carboxamide; Biguanides; Cell Line, Transformed; Cell Line, Tumor; Citric Acid Cycle; Endoplasmic Reticulum; Folic Acid; Glycerophosphates; Glycolysis; Humans; Lactates; Metabolome; Metformin; Neoplastic Stem Cells; Nucleotides; Phenformin; Ribonucleotides; src-Family Kinases; Tamoxifen

2014
Metformin inhibits tumor cell migration via down-regulation of MMP9 in tamoxifen-resistant breast cancer cells.
    Anticancer research, 2014, Volume: 34, Issue:8

    Topics: Breast Neoplasms; Cell Movement; Drug Resistance, Neoplasm; Female; Humans; Matrix Metalloproteinase 9; MCF-7 Cells; Metformin; Neoplasm Invasiveness; Promoter Regions, Genetic; Tamoxifen

2014
Automatic endpoint detection to support the systematic review process.
    Journal of biomedical informatics, 2015, Volume: 56

    Topics: Algorithms; Blood Glucose; Comparative Effectiveness Research; Data Mining; Electronic Data Processing; Evidence-Based Medicine; Female; Humans; Insulin; Language; Linear Models; Linguistics; Machine Learning; Metformin; Natural Language Processing; Raloxifene Hydrochloride; Randomized Controlled Trials as Topic; Reproducibility of Results; Support Vector Machine; Systematic Reviews as Topic; Tamoxifen; Uterus

2015
Anti-cancer effect of metformin by suppressing signaling pathway of HER2 and HER3 in tamoxifen-resistant breast cancer cells.
    Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine, 2016, Volume: 37, Issue:5

    Topics: Adenocarcinoma; Antineoplastic Agents; Antineoplastic Agents, Hormonal; Breast Neoplasms; Drug Resistance, Neoplasm; Enzyme Induction; ErbB Receptors; Estradiol; Female; Gene Expression Regulation, Neoplastic; Genes, erbB-1; Genes, erbB-2; Humans; Lapatinib; MCF-7 Cells; Metformin; Neoplasm Proteins; Neuregulin-1; Quinazolines; Receptor, ErbB-2; Receptor, ErbB-3; RNA Interference; RNA, Small Interfering; Signal Transduction; Tamoxifen; Tumor Stem Cell Assay

2016
The phenomenon of acquired resistance to metformin in breast cancer cells: The interaction of growth pathways and estrogen receptor signaling.
    IUBMB life, 2016, Volume: 68, Issue:4

    Topics: AMP-Activated Protein Kinases; Antineoplastic Agents, Hormonal; Cadherins; Cell Proliferation; Cyclin D1; Drug Resistance, Neoplasm; Estrogen Receptor alpha; Female; Gene Expression Regulation, Neoplastic; Humans; Hypoglycemic Agents; MCF-7 Cells; Metformin; NF-kappa B; Phosphorylation; Proto-Oncogene Proteins c-akt; Signal Transduction; Snail Family Transcription Factors; Tamoxifen; TOR Serine-Threonine Kinases

2016
Anticancer effect of metformin on estrogen receptor-positive and tamoxifen-resistant breast cancer cell lines.
    Oncology reports, 2016, Volume: 35, Issue:5

    Topics: Antineoplastic Agents, Hormonal; Breast Neoplasms; Cell Proliferation; Drug Resistance, Neoplasm; Drug Synergism; Estradiol; Estrogen Receptor alpha; Female; Gene Expression Regulation, Neoplastic; Humans; Inhibitory Concentration 50; MCF-7 Cells; Metformin; Tamoxifen; Transcriptional Activation

2016
[Evaluation of primary adherence to medications in patients with chronic conditions: A retrospective cohort study].
    Atencion primaria, 2018, Volume: 50, Issue:2

    Topics: Aged; Aged, 80 and over; Antineoplastic Agents, Hormonal; Breast Neoplasms; Chronic Disease; Cohort Studies; Diabetes Mellitus, Type 2; Diphosphonates; Female; Humans; Hypoglycemic Agents; Insulin; Male; Medication Adherence; Metformin; Middle Aged; Osteoporotic Fractures; Retrospective Studies; Tamoxifen

2018
Metformin alleviates endometrial hyperplasia through the UCA1/miR‑144/TGF‑β1/AKT signaling pathway.
    International journal of molecular medicine, 2020, Volume: 45, Issue:2

    Topics: Animals; Antineoplastic Agents, Hormonal; Apoptosis; Cell Line, Tumor; Endometrial Hyperplasia; Female; Gene Expression Regulation; Gene Expression Regulation, Neoplastic; Humans; Hypoglycemic Agents; Metformin; Mice; MicroRNAs; Proto-Oncogene Proteins c-akt; Signal Transduction; Tamoxifen; Transforming Growth Factor beta1

2020
Metformin suppresses proliferation and invasion of drug-resistant breast cancer cells by activation of the Hippo pathway.
    Journal of cellular and molecular medicine, 2020, Volume: 24, Issue:10

    Topics: Adaptor Proteins, Signal Transducing; Animals; Apoptosis; Breast Neoplasms; Cell Line, Tumor; Cell Nucleus; Cell Proliferation; Cell Survival; Drug Resistance, Neoplasm; Female; Hippo Signaling Pathway; Humans; MAP Kinase Kinase Kinases; Membrane Proteins; Metformin; Mice, Inbred BALB C; Models, Biological; Neoplasm Invasiveness; Neoplasm Metastasis; Paclitaxel; Protein Serine-Threonine Kinases; Protein Transport; Signal Transduction; Tamoxifen; Transcription Factors; Tumor Suppressor Proteins; YAP-Signaling Proteins

2020
A Triple Combination of Metformin, Acetylsalicylic Acid, and Oseltamivir Phosphate Impacts Tumour Spheroid Viability and Upends Chemoresistance in Triple-Negative Breast Cancer.
    Drug design, development and therapy, 2020, Volume: 14

    Topics: Aldehyde Dehydrogenase 1 Family; Antineoplastic Agents; Apoptosis; Aspirin; Breast Neoplasms; CD24 Antigen; Cell Proliferation; Cell Survival; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Humans; Hyaluronan Receptors; Metformin; Oseltamivir; Retinal Dehydrogenase; Spheroids, Cellular; Tamoxifen; Triple Negative Breast Neoplasms; Tumor Cells, Cultured

2020
ZNF423 modulates the AMP-activated protein kinase pathway and metformin response in a single nucleotide polymorphisms, estrogen and selective estrogen receptor modulator dependent fashion.
    Pharmacogenetics and genomics, 2021, 09-01, Volume: 31, Issue:7

    Topics: AMP-Activated Protein Kinases; Animals; Breast Neoplasms; Estrogens; Female; Humans; Metformin; Mice; Polymorphism, Single Nucleotide; Selective Estrogen Receptor Modulators; Tamoxifen

2021